Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

The Netherlands is a country with a low prevalence of multidrug-resistant organisms (MDRO), including carbapenemase-producing Enterobacterales (CPE), carbapenemase-producing Pseudomonas aeruginosa (CPPA), carbapenem-resistant Acinetobacter baumannii complex (CRAB) and meticillin-resistant Staphylococcus aureus (MRSA) [1–4]. Active MDRO screening and infection prevention measures (e.g. isolation of suspected colonised patients) applies to all patients admitted to a Dutch hospital who have recently been admitted to a hospital abroad (< 2 months ago for > 24 h) or resided in a centre for asylum seekers. Since March 2022, there has been an emergence of MDRO in the Netherlands in persons originating from Ukraine. Persons from whom isolates were obtained were receiving hospital care in the Netherlands and are henceforth referred to as patients. Here, we describe the epidemiology and genetic analysis of MDRO from patients from Ukraine in the Netherlands.

Effective Surveillance   Back